Andexanet alfa and heparin resistance in cardiac surgery: Experiences and risks associated with the reversal of direct oral anticoagulants

Eur J Cardiothorac Surg. 2023 Jun 1;63(6):ezad189. doi: 10.1093/ejcts/ezad189.
No abstract available

Keywords: Andexanet alfa; direct oral anticoagulants; heart-lung machine; heparin resistance.

Publication types

  • Comment

MeSH terms

  • Acute Aortic Syndrome*
  • Anticoagulants / adverse effects
  • Cardiac Surgical Procedures* / adverse effects
  • Heparin / adverse effects
  • Humans
  • United Kingdom

Substances

  • Heparin
  • PRT064445
  • Anticoagulants